Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:49:40.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 to reflect the latest build.
    Difference
    0.1%
    Check dated 2026-03-11T16:55:18.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and the previous funding/status notice (Revision: v3.4.1) has been removed; this appears to be a routine maintenance update with no impact on study data or user interaction. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T03:08:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T01:23:28.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Minor UI/text changes: a 'Show glossary' option is added; the QC update label now reads 'Last Update Submitted that Met QC Criteria' and a new 'Revision: v3.4.0' tag appears; footer text shows 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:17:20.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.